Narnolia

Narnolia

Toll Free No: 1800-103-7212

DIVIS LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE2161.40-28.65 (-1.31 %)
PREV CLOSE ( ) 2190.05
OPEN PRICE ( ) 2193.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 22330
TODAY'S LOW / HIGH ( )2157.00 2217.05
52 WK LOW / HIGH ( )1466.95 2537.7
NSE2161.10-29.35 (-1.34 %)
PREV CLOSE( ) 2190.45
OPEN PRICE ( ) 2219.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2161.10 (836)
VOLUME 932523
TODAY'S LOW / HIGH( ) 2157.00 2219.90
52 WK LOW / HIGH ( )1466 2537.95
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-10 1990
Management Info
Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director
Registered Office

Address 1-72/23(p)/divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 2378 6300

Email mail@divislaboratories.com

Website www.divislaboratories.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
09Mar Divi’s Laboratories starts commercial
Divi’s Laboratories has commenced commercial production effective from M..
09Mar Divis Laboratories informs about comme
Divis Laboratories has informed that the Company has commenced commercia..
01Feb USFDA completes inspection at Divi’s L
US Food and Drug Administration (USFDA) has completed inspection at Divi..
20Jan Divi' s Laboratories submits RTA certi
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..
31Dec Divi's Laboratories informs about trad
Divi's Laboratories has informed that pursuant to the SEBI (Prohibition..
Financials
Rs. in Millions
QTR Mar 20 ANNUAL 20
Net Profit391813727.1
Gross Profit 4752.2 18132.9
Operating Profit 5251.620053
Net Sales 13762.453105.7
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Procter&Gamble Healt (BSE)
peergroup  4254.45 (4.65%)
M.Cap ( in Cr)7062.12
Abbott India (BSE)
peergroup  15730.90 (0.44%)
M.Cap ( in Cr)33427.06
Valiant Organics (BSE)
peergroup  1713.60 (3.85%)
M.Cap ( in Cr)2081.89
Aarti Drugs (BSE)
peergroup  1321.55 (3.77%)
M.Cap ( in Cr)3079.21
Natco Pharma (BSE)
peergroup  691.20 (4.25%)
M.Cap ( in Cr)12584.54
Shareholding Pattern
PROMOTERS 51.97%
MUTUAL FUNDS/UTI 14.67%
NON-INSTITUTION 13.35%
FI/BANKS/INSURANCE 0.93%
GOVERNMENT 0%
FII 0%
About Divis Laboratories Ltd.

Divis Laboratories Ltd. was incorporated in the year 1990. Its today's share price is 2161.4. Its current market capitalisation stands at Rs 57378.38 Cr. In the latest quarter, company has reported Gross Sales of Rs. 49462.6 Cr and Total Income of Rs.51018.9 Cr. The company's management includes K V Chowdary, Sunaina Singh, S Ganapaty, Ramesh BV Nimmagadda, Ramesh BV Nimmagadda, KVK Seshavataram, R Ranga Rao, G Suresh Kumar, Nilima Motaparti, Kiran S Divi, Madhusudana Rao Divi, N V Ramana, Murali K Divi.

It is listed on the BSE with a BSE Code of 532488 , NSE with an NSE Symbol of DIVISLAB and ISIN of INE361B01024. It's Registered office is at 1-72/23(p)/divis/303,Divi Towers, Cyber Hills,GachibowliHyderabad-500032, Telangana. Their Registrars are ACC Ltd. It's auditors are Price Waterhouse Chartered Accountants LLP, PVRK Nageswara Rao & Co

Directory

current IPO
  • --
upcoming IPO
  • --
Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room